Pharmaceutical Grade 1009119-65-6 Daclatasvir For Treatment of Hepatitis C

Short Description:

Purity: ≧99.0%

Quality Standards: As required

Certificate: COA, MOA, MSDS, etc.

Capacity: 50Kgs per Month

Shelf Life: Two Years

Application: an inhibitor of nonstructural protein 5A and is used for treatment of hepatitis C

Team Advantage: Experienced export sales team with professional training in factory

Send email to us Download as PDF

Product Detail

FAQ

Product Tags

Product name	Daclatasvir 2HCl
Synonyms	N,N’-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride; BMS 790052
CAS No.	1009119-65-6
Appearance	White to pale yellow powder
Molecular Formula	C₄₀H₅₀N₈O₆.2(HCl)
Molecular Weight	811.81
Usage	Pharmaceutical Grade for Research purpose
Packing	As per your request
Storage	Preserve in tight,light-resistant containers in a cool place

Daclatasvir 2HCl Cas: 1009119-65-6
Items	Standard	Results
Characteristics	White to pale yellow powder	Pale-yellow powder
Water content	≦1.0%	0.25%
Purity	≧99%	99.7%
Single impurity	≦0.1%	0.06%
Residue on ignition	≦0.1%	Complies
Conclusion	Complies with the in-house specification.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsaf